- Samples are stored at various temperatures (e.g., -80°C, -20°C, 2–8°C, 25°C, or accelerated stress at 40°C).
- Humidity and light exposure may be controlled where relevant.
- Multiple storage conditions allow comparison and identification of the most favorable formulation environment.
Long-Term Stability Investigation Service for Antibody Formulation
Introduction
The long-term stability of therapeutic and research-grade antibodies is a critical parameter in ensuring product consistency, functionality, and reliability during storage and use. Antibodies are structurally complex biomolecules that can undergo chemical degradation, aggregation, denaturation, or loss of binding activity over time. Factors such as buffer composition, storage temperature, container type, and formulation excipients can profoundly influence stability outcomes.
Long-term stability investigations provide essential data on how antibody formulations behave under extended storage conditions, supporting rational decisions in experimental design, storage strategies, and process optimization. These investigations are especially important in identifying degradation pathways, estimating product shelf-life, and verifying the suitability of formulation components.
Fig.1 Objectives of Stability Testing.1
At Creative Biolabs, our Long-Term Stability Investigation Service for Antibody Formulation delivers comprehensive evaluation of antibody stability under controlled storage conditions. With a combination of advanced analytical tools and scientifically validated protocols, we provide detailed insights into molecular integrity, potency retention, and physical stability over time. This service ensures that researchers and developers can confidently rely on the consistency of their antibody formulations throughout extended use and storage.
Strategies
Our long-term stability investigation strategy integrates multiple complementary approaches to provide a thorough evaluation of antibody performance during prolonged storage.
Controlled Storage Conditions
Time-Point Sampling and Monitoring
- Stability studies are conducted over extended periods ranging from several weeks to more than 12 months.
- Antibody samples are analyzed at predefined time points (e.g., 1, 3, 6, 9, 12 months).
- Each time point provides critical information on degradation kinetics and long-term stability trends.
Comprehensive Analytical Characterization
To capture the full spectrum of stability outcomes, we employ a panel of analytical methods:
- Structural Integrity: SDS-PAGE, peptide mapping, and intact mass analysis.
- Purity & Aggregation: SEC-HPLC, DLS (Dynamic Light Scattering), and analytical ultracentrifugation.
- Charge Variants & Isoforms: cIEF (capillary isoelectric focusing) or ion-exchange chromatography.
- Binding Activity: ELISA, SPR, or BLI assays to monitor antigen-binding retention.
- Functional Evaluation: Cell-based potency assays if required.
Degradation Pathway Identification
- Detect oxidation, deamidation, clipping, or aggregation events.
- Evaluate whether degradation is chemical (modification of amino acids) or physical (aggregation, precipitation).
Data Analysis and Reporting
- Results are analyzed quantitatively and qualitatively to assess trends.
- Reports include stability profiles, graphical data (e.g., SEC chromatograms over time), and interpretations of potential risks.
- Recommendations are provided on formulation adjustments or storage strategies if instability is detected.
Required Materials
For accurate and reliable long-term stability assessment, the following materials and information should be provided:
- Antibody Samples: Minimum recommended concentration of 0.5–2 mg/mL; sufficient quantity for multiple time points across the intended study duration.
- Formulation Details: Complete buffer composition, pH, excipients, and additives.
- Packaging/Container Information: Type of storage vials, syringes, or bottles used for real-life storage conditions.
- Expected Storage Conditions: Desired temperature ranges and target storage period (short-term vs. extended stability).
- Previous Characterization Data (if available): Prior SEC, SDS-PAGE, or binding results to serve as baseline reference.
Samples should be shipped under validated cold-chain conditions to maintain stability prior to initiation of the study.
Publications
Long-term stability investigations have been widely documented in the scientific literature as essential steps in antibody formulation and process development. Representative applications include:
These studies collectively highlight the importance of long-term stability evaluation in predicting antibody performance and maintaining molecular integrity during storage.
FAQs
What storage conditions are typically evaluated in long-term stability studies?
Standard conditions include -80°C, -20°C, 2–8°C (refrigerated), 25°C (room temperature), and accelerated conditions such as 40°C. Custom conditions can also be arranged based on client requirements.
How long do stability studies usually last?
Duration may vary from a few weeks to more than 12 months depending on the goals of the study. Real-time stability studies generally cover 6–12 months, with additional accelerated studies available for faster assessments.
What analytical methods are included in the service?
Techniques such as SEC-HPLC, DLS, SDS-PAGE, peptide mapping, cIEF, and binding assays are employed to monitor purity, aggregation, structural integrity, and functional activity over time.
Can small-volume antibody samples be used?
While low-volume samples can be accommodated, sufficient material is needed for multiple time points. Clients are advised to provide adequate quantities to ensure complete datasets.
Does this service provide recommendations for formulation optimization?
Yes. Based on stability outcomes, we can recommend buffer modifications, excipients, or storage strategies to improve long-term antibody stability.
What type of degradation can be detected?
Both chemical degradation (oxidation, deamidation, hydrolysis) and physical degradation (aggregation, precipitation, fragmentation) are detectable through our multi-method analytical approach.
Contact Us
To learn more about our Long-Term Stability Investigation Service for Antibody Formulation, please contact Creative Biolabs. Our scientific team will guide you in designing customized stability studies, interpreting data, and developing strategies to ensure your antibody formulations remain stable and reliable over extended storage periods.
Reference
- González-González, Olga et al. "Drug Stability: ICH versus Accelerated Predictive Stability Studies." Pharmaceutics vol. 14,11 2324.Objectives of Stability Testing. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/pharmaceutics14112324
For research use only. Not intended for any clinical use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
